- Home
- MTEN vs LSTA Comparison
MTEN vs LSTA Comparison
Compare MTEN & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- LSTA
- Stock Information
- Founded
- MTEN 2015
- LSTA 1980
- Country
- MTEN China
- LSTA United States
- Employees
- MTEN N/A
- LSTA N/A
- Industry
- MTEN Building Products
- LSTA Misc Health and Biotechnology Services
- Sector
- MTEN Industrials
- LSTA Health Care
- Exchange
- MTEN Nasdaq
- LSTA Nasdaq
- Market Cap
- MTEN 82.6M
- LSTA 22.3M
- IPO Year
- MTEN 2024
- LSTA N/A
- Fundamental
- Price
- MTEN $11.75
- LSTA $2.28
- Analyst Decision
- MTEN
- LSTA Strong Buy
- Analyst Count
- MTEN 0
- LSTA 2
- Target Price
- MTEN N/A
- LSTA $23.50
- AVG Volume (30 Days)
- MTEN 60.9K
- LSTA 21.5K
- Earning Date
- MTEN 10-18-2025
- LSTA 11-11-2025
- Dividend Yield
- MTEN N/A
- LSTA N/A
- EPS Growth
- MTEN N/A
- LSTA N/A
- EPS
- MTEN N/A
- LSTA N/A
- Revenue
- MTEN $10,120,257.00
- LSTA $1,070,000.00
- Revenue This Year
- MTEN N/A
- LSTA N/A
- Revenue Next Year
- MTEN N/A
- LSTA N/A
- P/E Ratio
- MTEN N/A
- LSTA N/A
- Revenue Growth
- MTEN 23.03
- LSTA N/A
- 52 Week Low
- MTEN $3.20
- LSTA $1.87
- 52 Week High
- MTEN $26.03
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- MTEN 43.04
- LSTA 46.32
- Support Level
- MTEN $10.27
- LSTA $2.10
- Resistance Level
- MTEN $12.75
- LSTA $2.33
- Average True Range (ATR)
- MTEN 0.84
- LSTA 0.17
- MACD
- MTEN 0.09
- LSTA 0.01
- Stochastic Oscillator
- MTEN 56.92
- LSTA 43.75
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.